Loading insider details...
Beta
Latest Form 4 (Jul 2, 2026): Grant/Award of 32,000 FULC shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 32,000 | n/a |
| Feb 4, 2026 | Fulcrum Therapeutics, Inc. (FULC) | Sale | 15,000 | $160.9K |
| Jan 6, 2026 | Fulcrum Therapeutics, Inc. (FULC) | Sale | 15,000 | $178.1K |
| Nov 21, 2025 | Fulcrum Therapeutics, Inc. (FULC) | Sale | 15,000 | $165.5K |
| Jun 30, 2025 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 36,000 | n/a |
| Jul 2, 2024 | Turnstone Biologics Corp. (TSBX) | Grant/Award | 12,770 | n/a |
| Jun 18, 2024 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 30,000 | n/a |
| Jun 29, 2023 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 30,000 | n/a |
| Jan 13, 2023 | Fulcrum Therapeutics, Inc. (FULC) | Sale | 6,766 | $101.5K |
| Jun 29, 2022 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 19,000 | n/a |